← Back to all trials
Completed
NCT05708287
The Physiologic Effect of the Flow Generated by High Flow Nasal Cannula in Mild Respiratory Failure
Conditions: Respiratory Failure
Sex: All
Ages: 18 Years – 120 Years
Phase: NA
Enrollment: 28
Sponsor: Hadassah Medical Organization
Location: Israel
Summary
High flow nasal cannula (HFNC) oxygen therapy is increasingly used for hypoxemic respiratory failure and is proving useful in avoiding or delaying intubation and mechanical ventilation.
However, basic information regarding the physiologic effects of this method is missing.
In this study, the effects of oxygen delivery by HFNC on oxygenation, ventilation and cardiovascular vital signs in patients with mild hypoxemic respiratory failure were evaluated.
Eligibility Criteria
Inclusion Criteria:Minimal age 18The patient had invasive blood pressure monitoring via an arterial line in situThe patient had a mild respiratory failure manifested by the need for oxygen support via nasal prongs in order to maintain oxygen saturation (SpO2) above 90% for at least one hour prior to the start of the interventionExclusion Criteria:Shortness of breathPatients regularly using O2 at homeNo patient consent for participation
Source: ClinicalTrials.gov (NCT05708287). StuddyBuddy aggregates publicly available trial information.
